address1,city,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,52WeekChange,SandP52WeekChange,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,totalDebt,quickRatio,currentRatio,debtToEquity,returnOnAssets,returnOnEquity,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,shortName,corporateActions,regularMarketTime,longName,marketState,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,exchange,regularMarketChangePercent,regularMarketPrice,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,epsTrailingTwelveMonths,epsForward,twoHundredDayAverageChangePercent,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,trailingPegRatio
ScheelevAegen 2,Lund,223 63,Sweden,46 1 03 00 10 23,https://synactpharma.com,Biotechnology,biotechnology,Biotechnology,Healthcare,healthcare,Healthcare,"SynAct Pharma AB, a clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden. The company develops AP1189, a drug candidate in Phase 2 clinical trial for the treatment of rheumatoid arthritis, idiopathic membranous nephropathy, and virus-induced respiratory insufficiency. It is also developing TXP-11, an advanced peptide agonist that is in preclinical trials for the prevention of organ failure in surgery; and various drug programs to treat auto-immune and inflammatory diseases. SynAct Pharma AB was founded in 2012 and is headquartered in Lund, Sweden.",6,"[{'maxAge': 1, 'name': 'Mr. Jeppe Ovli Ovlesen EE, MBA', 'age': 62, 'title': 'Chief Executive Officer', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 3656000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Bjorn  Westberg', 'age': 62, 'title': 'Chief Financial Officer', 'yearBorn': 1962, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Thomas  Boesen Ph.D.', 'title': 'Chief Operating Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. James  Knight M.B.A.', 'title': 'Chief Business Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kristen  Harting M.D.', 'title': 'Chief Medical Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]",1672444800,[],86400,2,21.6,21.65,20.8,21.65,21.6,21.65,20.8,21.65,0.0,0.991,-11.994383,70414,70414,223960,182987,182987,21.3,21.45,1064820608,7.31,23.45,18.1942,14.267842,0.0,0.0,SEK,False,889492864,0.0,23912431,49874500,0.40085,0.09495,51949500,3.696,5.776515,1735603200,1767139200,1743379200,-82179000,-1.89,-1.78,1.5341246,0.11844492,EQUITY,21.35,25.0,25.0,25.0,25.0,0.0,strong_buy,1,51161000,1.044,1643000,5.906,6.46,0.907,-0.26604998,-0.49293,-74944496,-106834000,0.0,0.0,0.0,SEK,SYNACT.ST,en-US,US,Equity,Delayed Quote,True,HIGH,SynAct Pharma AB,[],1752161399,SynAct Pharma AB,PREPRE,finmb_333197769,Europe/Stockholm,CEST,7200000,se_market,False,STO,-1.1574074,21.35,False,1468220400000,-0.25,20.8 - 21.65,Stockholm,223960,14.040001,1.9206568,7.31 - 23.45,-2.1000004,-0.08955225,153.41246,-1.89,-1.78,0.49637204,3.1557999,0.17345087,7.082158,15,0,0.0 - Strong Buy,False,
